CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.58B
1-Year Return
14.63%
This Quarter Return
+8.31%
1 Year Return
+14.63%
3 Year Return
+71.56%
5 Year Return
+115.62%
10 Year Return
+272.08%
AUM
$2.94B
AUM Growth
+$119M
(+4.2%)
Cap. Flow
-$74.5M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
276
New
14
Increased
69
Reduced
146
Closed
11
Top Buys
| 1 |
Amazon
AMZN
|
$16.7M |
| 2 |
iShares Expanded Tech-Software Sector ETF
IGV
|
$10.2M |
| 3 |
SEI Investments
SEIC
|
$8.94M |
| 4 |
TJX Companies
TJX
|
$6.2M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
$5.62M |
Top Sells
| 1 |
Generac Holdings
GNRC
|
$15.7M |
| 2 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
$13.5M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$10.9M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
$10.1M |
| 5 |
Salesforce
CRM
|
$9.75M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Financials | 17.62% |
| 3 | Healthcare | 10.88% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Medtronic
MDT
$119B
| $204K | 0.01% |
2,624
+86
| +3% | +$6.68K |
|
|
PROF
252
Profound Medical
PROF
$133M
| $201K | 0.01% |
18,500
-4,200
| -19% | -$45.7K |
|
253
Ford
F
$46.5B
| $191K | 0.01% |
16,406
-3,785
| -19% | -$44K |
|
254
Editas Medicine
EDIT
$227M
| $139K | ﹤0.01% |
15,710
| – | – |
|
|
LMDX
255
DELISTED
LumiraDx Limited Common Shares
LMDX
| $124K | ﹤0.01% |
137,496
-7,804
| -5% | -$7.02K |
|
256
Vimeo
VMEO
$708M
| $96.4K | ﹤0.01% |
28,105
| – | – |
|
|
AGEN
257
Agenus
AGEN
$137M
| $79K | ﹤0.01% |
1,678
| – | – |
|
|
NAGE
258
Niagen Bioscience, Inc. Common Stock
NAGE
$743M
| $63.7K | ﹤0.01% |
37,925
| – | – |
|
259
Daktronics
DAKT
$857M
| $41K | ﹤0.01% |
40,989
| – | – |
|
260
Ginkgo Bioworks
DNA
$691M
| $31.2K | ﹤0.01% |
462
| – | – |
|
|
KLR
261
DELISTED
Kaleyra, Inc.
KLR
| $25.1K | ﹤0.01% |
9,500
| – | – |
|
262
Perspective Therapeutics
CATX
$263M
| $13.5K | ﹤0.01% |
5,482
| – | – |
|
263
Phunware
PHUN
$49.9M
| $11.6K | ﹤0.01% |
300
| – | – |
|
264
Compugen
CGEN
$132M
| $11.3K | ﹤0.01% |
15,720
| – | – |
|
265
Evogene
EVGN
$10.5M
| $9.8K | ﹤0.01% |
1,400
| – | – |
|
266
CrowdStrike
CRWD
$104B
| – | – |
-1,450
| Closed | -$239K |
|
267
Airbnb
ABNB
$76.8B
| – | – |
-1,905
| Closed | -$200K |
|
268
Brookfield Renewable
BEP
$7.09B
| – | – |
-12,782
| Closed | -$400K |
|
269
Brookfield
BN
$99.6B
| – | – |
-8,186
| Closed | -$271K |
|
270
F5
FFIV
$18.1B
| – | – |
-1,804
| Closed | -$261K |
|
|
271
Generac Holdings
GNRC
$10.5B
| – | – |
-88,105
| Closed | -$15.7M |
|
272
Goldman Sachs
GS
$227B
| – | – |
-150
| Closed | -$44K |
|
273
Lam Research
LRCX
$127B
| – | – |
-5,940
| Closed | -$217K |
|
274
Schwab Emerging Markets Equity ETF
SCHE
$10.7B
| – | – |
-10,856
| Closed | -$243K |
|
275
SPDR S&P Biotech ETF
XBI
$5.28B
| – | – |
-3,095
| Closed | -$245K |
|